Xeris Biopharma Ownership | Who Owns Xeris Biopharma?


OverviewForecastRevenueFinancialsChartTranscripts

Xeris Biopharma Ownership Summary


Xeris Biopharma is owned by 18.83% institutional investors, 3.93% insiders, and 77.24% retail investors. Blackrock is the largest institutional shareholder, holding 7.35% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.83% of its assets in Xeris Biopharma shares.

XERS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockXeris Biopharma18.83%3.93%77.24%
SectorHealthcare Stocks 57.32%9.83%32.85%
IndustryBiotech Stocks 68.45%9.51%22.05%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock10.33M7.35%$23.25M
Blackrock funding, inc. /de10.82M7.26%$36.68M
Vanguard group7.90M5.30%$26.78M
State street3.26M2.32%$7.33M
Geode capital management3.35M2.25%$11.36M
Rosalind advisors3.10M2.08%$10.53M
Aigh capital management2.57M1.73%$8.73M
Renaissance2.10M1.41%$7.12M
Caxton2.02M1.35%$6.83M
Millennium management1.95M1.31%$6.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caxton2.02M41.06%$6.83M
Rosalind advisors3.10M5.38%$10.53M
Aigh capital management2.57M2.73%$8.73M
Knott david m jr1.00M1.23%$3.39M
Stonepine capital management182.32K0.50%$618.05K
Essex investment management474.95K0.29%$1.61M
Parkman healthcare partners578.51K0.26%$1.96M
Centerbook partners lp690.08K0.14%$2.34M
Alpine global management160.00K0.13%$542.40K
Eam investors222.38K0.11%$753.86K

Top Buyers

HolderShares% AssetsChange
Ubs group1.73M0.00%1.45M
Goldman sachs group1.59M0.00%754.14K
Jpmorgan chase1.04M0.00%651.48K
Millennium management1.95M0.00%502.85K
Renaissance2.10M0.01%500.12K

Top Sellers

HolderShares% AssetsChange
Bioimpact capital---4.83M
Caxton2.02M41.06%-3.10M
Centerbook partners lp690.08K0.14%-2.79M
Walleye capital---1.12M
Redmile group451.10K0.11%-595.49K

New Positions

HolderShares% AssetsChangeValue
Essex investment management474.95K0.29%474.95K$1.61M
Eam investors222.38K0.11%222.38K$753.86K
Stonepine capital management182.32K0.50%182.32K$618.05K
Legato capital management142.16K0.06%142.16K$481.94K
Globeflex capital l p125.21K0.04%125.21K$424.46K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-27.00
American capital advisory-50.00
Soa wealth advisors, llc.-118.00
Comerica bank-417.00
Federation des caisses desjardins du quebec-570.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202468-53.42%28,055,641-56.11%181.02%34-53.42%9-73.53%
Sep 30, 20241434.38%63,815,8025.21%422.30%711.43%34-5.56%
Jun 30, 2024137-6.16%60,658,0950.07%432.32%70-17.65%369.09%
Mar 31, 202414619.67%60,615,6811.47%432.31%8549.12%336.45%
Dec 31, 20231227.02%59,735,5648.86%432.74%579.62%3119.23%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.22M2.83%-
iShares Russell 2000 ETF3.63M2.43%-70.97K
Vanguard Institutional Extnd Mkt Idx Tr2.36M1.58%856.00
CREF Stock R11.48M0.99%-
Fidelity Small Cap Index1.44M0.96%10.94K
iShares Russell 2000 Growth ETF1.24M0.83%-1.46K
State St Russell Sm/Mid Cp® Indx NL Cl C851.74K0.57%-
Fidelity Extended Market Index821.19K0.55%-6.62K
Vanguard Russell 2000 ETF627.70K0.42%-41.18K
Kennedy Micro Cap567.91K0.38%41.84K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 12, 2024Schmid John P.-Buy$10.15K
Aug 09, 2024Schmid John P.-Buy$10.13K
May 10, 2024Schmid John P.-Buy$10.31K
Mar 14, 2024Schmid John P.-Buy$9.72K
Nov 27, 2023SHERMAN JEFFREY W-Buy$10.10K

Insider Transactions Trends


DateBuySell
2024 Q32-
2024 Q21-
2024 Q11-
2023 Q46-
2023 Q31-

XERS Ownership FAQ


Who Owns Xeris Biopharma?

Xeris Biopharma shareholders are primarily institutional investors at 18.83%, followed by 3.93% insiders and 77.24% retail investors. The average institutional ownership in Xeris Biopharma's industry, Biotech Stocks , is 68.45%, which Xeris Biopharma falls below.

Who owns the most shares of Xeris Biopharma?

Xeris Biopharma’s largest shareholders are Blackrock (10.33M shares, 7.35%), Blackrock funding, inc. /de (10.82M shares, 7.26%), and Vanguard group (7.9M shares, 5.30%). Together, they hold 19.92% of Xeris Biopharma’s total shares outstanding.

Does Blackrock own Xeris Biopharma?

Yes, BlackRock owns 7.35% of Xeris Biopharma, totaling 10.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 23.25M$. In the last quarter, BlackRock increased its holdings by 371.57K shares, a 3.73% change.

Who is Xeris Biopharma’s biggest shareholder by percentage of total assets invested?

Caxton is Xeris Biopharma’s biggest shareholder by percentage of total assets invested, with 41.06% of its assets in 2.02M Xeris Biopharma shares, valued at 6.83M$.

Who is the top mutual fund holder of Xeris Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Xeris Biopharma shares, with 2.83% of its total shares outstanding invested in 4.22M Xeris Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools